1. Home
  2. TIL vs TWIN Comparison

TIL vs TWIN Comparison

Compare TIL & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • TWIN
  • Stock Information
  • Founded
  • TIL 2018
  • TWIN 1918
  • Country
  • TIL United States
  • TWIN United States
  • Employees
  • TIL N/A
  • TWIN N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • TWIN Industrial Machinery/Components
  • Sector
  • TIL Health Care
  • TWIN Industrials
  • Exchange
  • TIL Nasdaq
  • TWIN Nasdaq
  • Market Cap
  • TIL 177.1M
  • TWIN 186.2M
  • IPO Year
  • TIL 2021
  • TWIN N/A
  • Fundamental
  • Price
  • TIL $20.99
  • TWIN $14.66
  • Analyst Decision
  • TIL Strong Buy
  • TWIN Strong Buy
  • Analyst Count
  • TIL 5
  • TWIN 1
  • Target Price
  • TIL $100.67
  • TWIN $12.00
  • AVG Volume (30 Days)
  • TIL 165.7K
  • TWIN 36.1K
  • Earning Date
  • TIL 11-12-2025
  • TWIN 11-05-2025
  • Dividend Yield
  • TIL N/A
  • TWIN 1.13%
  • EPS Growth
  • TIL N/A
  • TWIN N/A
  • EPS
  • TIL N/A
  • TWIN N/A
  • Revenue
  • TIL N/A
  • TWIN $340,738,000.00
  • Revenue This Year
  • TIL N/A
  • TWIN $10.79
  • Revenue Next Year
  • TIL N/A
  • TWIN $8.43
  • P/E Ratio
  • TIL N/A
  • TWIN N/A
  • Revenue Growth
  • TIL N/A
  • TWIN 15.46
  • 52 Week Low
  • TIL $10.80
  • TWIN $6.16
  • 52 Week High
  • TIL $45.07
  • TWIN $14.93
  • Technical
  • Relative Strength Index (RSI)
  • TIL 49.49
  • TWIN 63.41
  • Support Level
  • TIL $17.37
  • TWIN $13.48
  • Resistance Level
  • TIL $21.45
  • TWIN $14.56
  • Average True Range (ATR)
  • TIL 1.48
  • TWIN 0.70
  • MACD
  • TIL 0.47
  • TWIN -0.08
  • Stochastic Oscillator
  • TIL 89.09
  • TWIN 72.23

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

Share on Social Networks: